Latest news
18.03.2025
EMIS released 34 indicators through the ECDC for the 2024 Dublin Declaration Monitoring (DDM) report. These indicators apply to MSM (both cis and trans) and individuals assigned male at birth who identify as nonbinary. All indicators are stratified by age group (<25, 25+), with three further stratified by HIV diagnosis. This release occurred ahead of the official data publication to collaborating partners to meet DDM deadlines. As requested in the DDM forms, we provide numerator and denominator counts, along with percentages when the denominator includes at least 20 cases.
14.02.2025
50,330 Respondents
EMIS-2024 recruitment closed on June 30, 2024, with 55,000 responses. It took until February 2025 to merge 35 language versions, process, and clean the data. After cleaning, there are 50,330 respondents with valid data.
This number includes 2,658 individuals who identified as part of the trans community, the highest number recorded across all EMIS waves.
The EMIS-2024 variable manual is now available under publications. We are currently drafting the methods paper, which we hope to have available by summer, and the European Report. National funders will receive the Data Transfer Agreement for their respective national data subsets by the end of February for review and signature. Network members will be notified once the EMIS-2024 Scientific Board is established and data requests are ready to be processed — not before April.
Past updates
Project
The European MSM Internet Survey (EMIS) is a multi-country, multi-language, anonymous online survey for gay, bisexual, and other men who have sex with men (MSM).
EMIS is a joint project of community, academic, and governmental partners across Europe, to inform sexual health interventions for MSM. It occurred in 2010 and 2017 with core-funding from the European Union Health Programme. Since October 2023, we have managed to establish sufficient funding for repeating EMIS, with data collection in the first half of 2024.
EMIS-2024 is executed by a consortium of three partners: Deutsche Aidshilfe (DAH), Maastricht University, and Robert Koch Institute (RKI). Team DAH: Dr. Axel J. Schmidt (co-principal investigator), Dr. Tamás Bereczky (coordinator EEA/CH/IL), with the support of Dr. Dirk Sander, Jonathan Gregory, Ferenc Bagyinszky, Alexandra Gurinova, Silke Klumb. Team Maastricht: Prof. Dr. Kai J. Jonas (co-principal investigator), Liana Aphami (data coordinator), Jules L. Casalini (trans sub-survey coordinator). Team RKI: Dr. Ulrich Marcus (co-principal investigator), Dr. Nikolay Lunchenkov (coordinator EECA).
EMIS-2024 is co-funded by the European Centre for Disease Prevention and Control (ECDC) and the following countries: BE, CH, DE, EE, ES, IE, IL, LU, NL, NO, PT, and SE. For details see EMIS-2024 Network. One of the key benefits of EMIS has been the possibility of completing the questionnaire in all of the official languages of the European Economic Area (EEA). This is particularly important for countries with large proportions of migrants from Southern, Eastern, or South-eastern Europe.
In EMIS-2024 we cover 50 countries and 35 languages.
Countries receiving national funding are shown in dark blue, while those in lighter shades of blue are included without funding, as their national languages are already covered. Countries co-funded by ECDC are highlighted in light green. Countries receiving funding from Germany’s Global Health Protection Programme (GHPP) are highlighted in dark green.
Previous EMIS rounds also included Belarus, as well as Lebanon, Canada, and the Philippines outside the WHO European Region. EMIS was coordinated by Deutsche Aidshilfe (DAH) and Robert Koch Institute (RKI), as illustrated in the following map.
